Abstract:We aim to evaluate 18F-NaF uptake by facet joints with hybrid PET-CT technique. Specifically, we evaluate NaF uptake in the facet joints of the lower lumbar spine, and correlate with the morphologic grade of facet arthropathy on CT. 30 consecutive patients who underwent standard vertex to toes NaF PET-CT for re-staging of primary neoplastic disease without measurable or documented bony metastases were identified. Maximum (SUVmax) and average (SUVavg) standardized uptake values were calculated for each L3-4, L4… Show more
“…This finding is consistent with a previous study wherein a similarly weak correlation was found between NaF-PET uptake and CT measures of facet arthropathy, further supporting the hypothesis that physiologic information afforded by NaF uptake may supplement conventional structural imaging for identifying symptomatic facet joints. 6 …”
Section: Discussionmentioning
confidence: 99%
“…3–5 The utility of 18 F-NaF PET for evaluating degenerative disease of the lumbar spine remains largely unexplored. 6 …”
To prospectively evaluate the relationship between low back pain-related disability and quantitative measures from dynamic sodium fluoride (18F-NaF) PET-MRI. Six patients with facetogenic low back pain underwent dynamic 18F-NaF PET/MRI. PET metrics were correlated with clinical measures and MRI grading of lumbar facet arthropathy. Significant positive correlation was observed between maximum FJ uptake rate and clinical disability (p < 0.05). These data suggest dynamic 18F-NaF PET may serve as a useful biomarker for facetogenic disability.
“…This finding is consistent with a previous study wherein a similarly weak correlation was found between NaF-PET uptake and CT measures of facet arthropathy, further supporting the hypothesis that physiologic information afforded by NaF uptake may supplement conventional structural imaging for identifying symptomatic facet joints. 6 …”
Section: Discussionmentioning
confidence: 99%
“…3–5 The utility of 18 F-NaF PET for evaluating degenerative disease of the lumbar spine remains largely unexplored. 6 …”
To prospectively evaluate the relationship between low back pain-related disability and quantitative measures from dynamic sodium fluoride (18F-NaF) PET-MRI. Six patients with facetogenic low back pain underwent dynamic 18F-NaF PET/MRI. PET metrics were correlated with clinical measures and MRI grading of lumbar facet arthropathy. Significant positive correlation was observed between maximum FJ uptake rate and clinical disability (p < 0.05). These data suggest dynamic 18F-NaF PET may serve as a useful biomarker for facetogenic disability.
“…Not only does NaF-PET/CT facilitate the diagnosis of pars stress but it can also help diagnose other potential causes of back pain, such as facet arthropathy. [80][81][82] The observation that NaF uptake at the cervical, thoracic, and lumbar spine is associated with increased body weight in healthy individuals suggests that NaF-PET/CT can detect early changes in the spine related to degeneration. 83 In 42 adult patients with back pain and no history of spine surgery, NaF-PET/CT scans identified the cause of pain in 37 (88%) of the patients.…”
Section: Back Painmentioning
confidence: 99%
“…82 Furthermore, NaF activity at lumbar facet joints has been found to correlate with both MR findings and clinical disability. 80 Mabray and colleagues 81 observed that, in 30 adult patients who underwent imaging by NaF-PET/CT, uptake of NaF was only weakly correlated with CT Pathria grade of facet osteoarthropathy. Thereby, the investigators reasoned that the assessment of bone turnover with NaF provided new information that can be used to supplement structural data provided by CT.…”
The bone-seeking properties of 18 F-sodium fluoride (NaF) were first described in 1962 by Blau and colleagues, 1 who used this positron-emitting radiotracer in skeletal scintigraphy. Both high uptake by bone and rapid plasma clearance of NaF were determined to be advantages in imaging skeletal metabolism. 2 The mechanism of NaF uptake relies on the exchange of OH À for 18 F À , converting hydroxyapatite on the surface of the bone matrix to fluorapatite. 2,3 One hour after NaF is administered intravenously, only 10% remains in the plasma compartment because of a first-pass Conflict of interest: The authors have declared no conflicts of interest.
“…36,40 Additionally, increased F 18 -NaF uptake was shown to correlate well with those patients with facet joint pain. [41][42][43] Further, significantly increased F 18 -NaF PET subchondral bone uptake was observed in a patient population at risk for developing degenerative joint disease. 44 These findings support the hypothesis that increased metabolic bone activity detected with F 18 -NaF PET can serve as a marker for early bone remodeling in OA.…”
Section: F 18 -Sodium Fluoride Pet/mri For Osteoarthritismentioning
Identifying the source of a person's pain is a significant clinical challenge because the physical sensation of pain is believed to be subjective and difficult to quantify. The experience of pain is not only modulated by the individual's threshold to painful stimuli but also a product of the person's affective contributions, such as fear, anxiety, and previous experiences. Perhaps then to quantify pain is to examine the degree of nociception and pro-nociceptive inflammation, that is, the extent of cellular, chemical, and molecular changes that occur in pain-generating processes. Measuring changes in the local density of receptors, ion channels, mediators, and inflammatory/immune cells that are involved in the painful phenotype using targeted, highly sensitive, and specific positron emission tomography (PET) radiotracers is therefore a promising approach toward objectively identifying peripheral pain generators. Although several preclinical radiotracer candidates are being developed, a growing number of ongoing clinical PET imaging approaches can measure the degree of target concentration and thus serve as a readout for sites of pain generation. Further, when PET is combined with the spatial and contrast resolution afforded by magnetic resonance imaging, nuclear medicine physicians and radiologists can potentially identify pain drivers with greater accuracy and confidence. Clinical PET imaging approaches with fluorine-18 fluorodeoxyglucose, fluorine-18 sodium fluoride, and sigma-1 receptor PET radioligand and translocator protein radioligands to isolate the source of pain are described here.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.